澳洋順昌(002245.SZ):公司名稱已變更為“江蘇蔚藍鋰芯股份有限公司”
格隆匯 12 月 8日丨澳洋順昌(002245.SZ)公佈,2020年12月8日,公司已完成上述工商變更登記相關手續,領取了蘇州市市場監督管理局簽發的變更後的營業執照。公司名稱已變更為:江蘇蔚藍鋰芯股份有限公司(英文名稱:Jiangsu Azure Corporation),公司經營範圍已變更為:電池製造;其他電子器件製造;金屬材料銷售;技術服務、技術開發、技術諮詢、技術交流、技術轉讓、技術推廣。
公司後續將做好公司名稱變更的相關工作,同時,將向深圳證券交易所申請變更證券簡稱,公司證券代碼將保持不變,公司將按照相關規定披露進展情況。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.